Hunan Er-kang Pharmaceutical (300267.SZ): Sodium hydroxide raw material drug listing application approved.
Erkang Pharmaceuticals (300267.SZ) announced that the company recently received the "Approval Notice for Application for Marketing of Sodium Hydroxide Raw Materials" issued by the National Medical Products Administration. Sodium hydroxide is a pH regulator drug. This approval further enriches the company's variety of raw materials and enhances the company's product market competitiveness, which will have a positive impact on the future market expansion and sales of the above-mentioned products.
Hunan Er-kang Pharmaceutical (300267.SZ) announced that the company recently received a Notice of Approval for the listing application of the raw material drug Sodium Hydroxide issued by the National Medical Products Administration. Sodium Hydroxide belongs to pH value regulating drugs. This approval further enriches the company's raw material drug varieties and will help enhance the competitiveness of the company's products in the market, bringing positive impacts to the future market expansion and sales of the aforementioned products.
Related Articles
Metallurgical Corporation of China (01618) repurchased 2.054 million shares at a cost of HK$2.8752 million on July 3.
PACIFICTEXTILES (01382) has spent HK$346,000 on July 3 to repurchase 403,000 shares.
WEIGAO GROUP (01066) spent approximately 129,600 Hong Kong dollars on July 3 to repurchase 40,000 shares.
Metallurgical Corporation of China (01618) repurchased 2.054 million shares at a cost of HK$2.8752 million on July 3.
PACIFICTEXTILES (01382) has spent HK$346,000 on July 3 to repurchase 403,000 shares.
WEIGAO GROUP (01066) spent approximately 129,600 Hong Kong dollars on July 3 to repurchase 40,000 shares.
RECOMMEND
